IOVANCE BIOTHERAPEUTICS, INC. Conversion of Stock, Shares Converted
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) reported Conversion of Stock, Shares Converted of 1.52 million shares for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-11-06.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:ConversionOfStockSharesConverted1 · last filed 2018-11-06
- IOVANCE BIOTHERAPEUTICS, INC. conversion of stock, shares converted for the quarter ending 2018-09-30 was 272.85K shares.
- IOVANCE BIOTHERAPEUTICS, INC. conversion of stock, shares converted for the quarter ending 2015-09-30 was 0.00 shares.
- IOVANCE BIOTHERAPEUTICS, INC. conversion of stock, shares converted for the quarter ending 2015-06-30 was 0.00 shares.
- IOVANCE BIOTHERAPEUTICS, INC. conversion of stock, shares converted for the quarter ending 2015-03-31 was 2.00K shares.
| Period end | Conversion of Stock, Shares Converted 3 month | Conversion of Stock, Shares Converted 6 month | Conversion of Stock, Shares Converted 9 month |
|---|---|---|---|
| 2018-09-30 | 272.85K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | 1.52M shares 10-Q · filed 2018-11-06 | |
| 2018-06-30 | 1.25M shares 10-Q · filed 2018-08-07 | ||
| 2015-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | 0.00 shares derived: sum of 2 quarters · filed 2015-11-06 | 2.00K shares 10-Q · filed 2015-11-06 |
| 2015-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | 2.00K shares 10-Q · filed 2015-08-10 | |
| 2015-03-31 | 2.00K shares 10-Q · filed 2015-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |